Inner Mongolia Shengxue Dacheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Inner Mongolia Company") was established in 2018. It is a modern pharmaceutical enterprise jointly funded by China Uranium Industry Co., Ltd. and Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. (Dacheng Pharmaceutical). The company is located in Kailu County Industrial Park, Tongliao City, Inner Mongolia Autonomous Region. It has a registered capital of 220 million yuan and a total land area of approximately 1,000 mu. The high-end pharmaceutical base project of Inner Mongolia Company is constructed in three phases. Its main construction covers production lines and supporting facilities for Oxytetracycline, Oxytetracycline Hydrochloride, Tetracycline, Streptomycin Sulfate, Dihydrostreptomycin, Neomycin, Minocycline Hydrochloride, Vitamin B2, as well as premixes including Oxytetracycline Calcium, Enramycin, Chlortetracycline, Bacitracin, Nosiheptide and Avilamycin. The Phase I project, with an investment of 1 billion yuan, features an annual output of 5,000 tons of APIs and was completed and put into operation in 2019. The Phase II project is planned to invest 1 billion yuan for a 5,000-ton green animal health product series project, while the Phase III project with an estimated investment of 1 billion yuan focuses on high-end pharmaceutical preparations. Upon full completion and operation of all phases, the company is expected to achieve an annual sales revenue of 3 billion yuan, profits and taxes of 300 million yuan, and provide 2,000 jobs. At present, the Phase I project has been officially commissioned. All core products of the company have passed national GMP certification, national veterinary GMP certification and obtained Japanese official certification. The company’s products sell well across China and are exported to dozens of countries and regions in Europe, America, Southeast Asia, the Middle East, India, North Africa, South America and other areas. It has established long-term strategic cooperative partnerships with global leading pharmaceutical and animal health enterprises including Pfizer, Zoetis, Abbott and Cargill.
